EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Recent Advances in the Development of Liquid Crystalline Nanoparticles as Drug Delivery Systems

Jassica S L Leu, Jasy J X Teoh, Angel L Q Ling, Joey Chong, Yan Shan Loo iD, Intan Diana Mat Azmi iD, Noor Idayu Zahid iD, Rajendran J C Bose iD, Thiagarajan Madheswaran

Pharmaceutics · 06.05.2023 · 15 (5) · 1421

DOI: 10.3390/pharmaceutics15051421 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Pharmaceutics, online erschienen am 06.05.2023. Verfasst von Jassica S L Leu und 8 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, International Medical University, Jalan Jalil Perkasa 19, Bukit Jalil, Kuala Lumpur 57000, Selangor, Malaysia. Die Arbeit wurde bisher 58-mal zitiert (Crossref) und nennt 134 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: International Medical University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Due to their distinctive structural features, lyotropic nonlamellar liquid crystalline nanoparticles (LCNPs), such as cubosomes and hexosomes, are considered effective drug delivery systems. Cubosomes have a lipid bilayer that makes a membrane lattice with two water channels that are intertwined. Hexosomes are inverse hexagonal phases made of an infinite number of hexagonal lattices that are tightly connected with water channels. These nanostructures are often stabilized by surfactants. The structure’s membrane has a much larger surface area than that of other lipid nanoparticles, which makes it possible to load therapeutic molecules. In addition, the composition of mesophases can be modified by pore diameters, thus influencing drug release. Much research has been conducted in recent years to improve their preparation and characterization, as well as to control drug release and improve the efficacy of loaded bioactive chemicals. This article reviews current advances in LCNP technology that permit their application, as well as design ideas for revolutionary biomedical applications. Furthermore, we have provided a summary of the application of LCNPs based on the administration routes, including the pharmacokinetic modulation property.

Schlagwörter

Stichwörter der Autor:innen

cubosomesdrug delivery systemshexosomesliquid crystalline nanoparticles (LCNPs)theranosticsvaccine delivery

Autor:innen und Institutionen

  • School of Pharmacy, International Medical University, Jalan Jalil Perkasa 19, Bukit Jalil, Kuala Lumpur 57000, Selangor, Malaysia.
  • Department of Chemistry, Faculty of Science, Universiti Putra Malaysia, Serdang 43400, Selangor, Malaysia.
  • Centre for Fundamental and Frontier Sciences in Nanostructure Self-Assembly, Department of Chemistry, Faculty of Science, Universiti Malaya, Kuala Lumpur 50603, Selangor, Malaysia.
  • Masonic Medical Research Institute, 2150 Bleecker St, Utica, NY 13501, USA.
  • Department of Pharmaceutical Technology, School of Pharmacy, International Medical University, Jalan Jalil Perkasa 19, Bukit Jalil, Kuala Lumpur 57000, Selangor, Malaysia.

ORCID-Profile: Yan Shan Loo, Intan Diana Mat Azmi, Noor Idayu Zahid, Rajendran J C Bose

Förderung

  • International Medical University

Zitieren

APA

Leu, J. S. L., Teoh, J. J. X., Ling, A. L. Q., Chong, J., Loo, Y. S., Mat Azmi, I. D., Zahid, N. I., Bose, R. J. C., & Madheswaran, T. (2023). Recent Advances in the Development of Liquid Crystalline Nanoparticles as Drug Delivery Systems. Pharmaceutics, 15(5), 1421. https://doi.org/10.3390/pharmaceutics15051421

Vancouver

Leu JSL, Teoh JJX, Ling ALQ, Chong J, Loo YS, Mat Azmi ID, et al. Recent Advances in the Development of Liquid Crystalline Nanoparticles as Drug Delivery Systems. Pharmaceutics. 2023;15(5):1421. doi:10.3390/pharmaceutics15051421

BibTeX
@article{Leu2023,
  author = {Leu, Jassica S L and Teoh, Jasy J X and Ling, Angel L Q and Chong, Joey and Loo, Yan Shan and Mat Azmi, Intan Diana and Zahid, Noor Idayu and Bose, Rajendran J C and Madheswaran, Thiagarajan},
  title = {Recent Advances in the Development of Liquid Crystalline Nanoparticles as Drug Delivery Systems},
  journal = {Pharmaceutics},
  year = {2023},
  volume = {15},
  number = {5},
  pages = {1421},
  doi = {10.3390/pharmaceutics15051421}
}
Kostenlos starten →